Industry: Healthcare | Lastest Edition: May 7, 2026 | No of Pages: 203 | No. of Tables: 85 | No. of Figures: 74 | Format: PDF | Report Code : HC1130
The Vietnam Professional Acne Medication Market size was valued at USD 46.48 million in 2025 and is expected to reach USD 53.61 million by 2026. Looking ahead, the industry is projected to expand rapidly, reaching USD 122.89 million by 2035, registering a CAGR of 9.66% from 2026 to 2035.
The Vietnam professional acne medication market is in a formative stage, shaped by rapid urbanisation, changing lifestyles, and rising awareness of dermatological health. Acne prevalence is increasing among adolescents and young adults, driven by pollution exposure, dietary shifts, and stress associated with fast-paced urban living. Professional treatment adoption is strongest in major cities, where private dermatology clinics and hospitals are expanding, and patients are more willing to seek specialist care after limited success with over-the-counter products. Prescription therapies are typically used for inflammatory or persistent acne, alongside basic skincare guidance rather than intensive procedural intervention. Market development is influenced by affordability, uneven specialist access, and evolving regulatory frameworks, which moderate the pace of expansion. Despite these constraints, improving healthcare access and growing interest in clinician-led skin treatment are gradually strengthening Vietnam’s professional acne medication market.
The professional acne medication market in Vietnam is being shaped by a young population and rapidly evolving urban lifestyles. Vietnam’s cities are experiencing increased exposure to pollution, humidity, irregular diets, and work–study pressure, all of which contribute to rising acne incidence among teenagers and young adults. Clear skin is increasingly associated with confidence, employability, and social presence, particularly in urban centres. As awareness grows about acne-related scarring and pigmentation, consumers are becoming more open to dermatologist-guided treatments rather than relying solely on traditional or cosmetic remedies. This behavioural shift is gradually expanding the acceptance of prescription-grade acne medications, especially among digitally connected youth who actively seek credible and long-term solutions.
Expansion of private healthcare services is playing a central role in strengthening Vietnam’s professional acne medication market. Private hospitals, dermatology clinics, and aesthetic centres are increasing in number, particularly in major cities, offering specialised skin treatments and quicker access to care. Dermatologists are increasingly trusted for accurate diagnosis and structured acne management plans, which boosts prescription rates. In parallel, rising health awareness through online platforms and clinic-led education is helping consumers differentiate between cosmetic skincare and medical treatment. Improved availability of trained specialists and modern treatment protocols is creating a more supportive ecosystem for professional acne medications, driving gradual but steady market growth.
A key restraint in Vietnam’s professional acne medication market is strong price sensitivity combined with reliance on non-prescription alternatives. Many consumers initially opt for over-the-counter products, herbal remedies, or informal advice due to lower costs and cultural familiarity. Professional acne treatments require sustained use and follow-up visits, which be perceived as financially demanding, especially among students and early-career professionals. This leads to delayed medical consultation and inconsistent treatment adherence. As a result, prescription medications are more commonly adopted for moderate-to-severe cases, limiting broader penetration and slowing overall market expansion.
Vietnam offers strong growth potential through affordable and education-focused acne treatment strategies. Cost-effective formulations, simplified regimens, and flexible pricing significantly improve access for younger populations. Increased patient education, both online and in clinics, encourages earlier intervention and better adherence. Tele-dermatology and digital follow-ups also present opportunities to extend specialist care beyond major cities. As consumers become more informed about the long-term benefits of professional treatment, acne medications that balance affordability, effectiveness, and accessibility are well-positioned to drive sustained growth in Vietnam’s evolving dermatology market.
The Vietnam professional acne medication industry comprises various market players, such as Bayer AG, Pfizer Inc., GlaxoSmithKline group of companies, Pfizer Inc., F. Hoffmann-La Roche, Galderma, Vinapharco, BEIERSDORF, Dermafirm, MD CARE CO., LTD., Bioderma, Bo International Pvt. Ltd., Glenmark Pharmaceuticals Ltd., Kenvue Inc., Rixin Cosmetics Co., Ltd and others.
Inflammatory Acne
Papules & Pustules
Nodules
Cystic Acne
Non-Inflammatory Acne
Open Comedones
Closed Comedones
Topical Medications
Gels
Creams
Lotions
Other Tropical Medications
Combination Treatments
Laser and Light-Based Treatments
Blue Light Therapy
Intense Pulsed Light
Photodynamic Therapy
Oral Medications
Tablets
Capsules
Oral Suspensions
Mild Acne
Moderate Acne
Severe Acne
Post-Inflammatory Hyperpigmentation (Pih)
Normal/Combination Skin
Dry Skin
Oily Skin
Sensitive Skin
Pediatric Patients (≤12 years)
Teenagers and Young Adults (13-30 years)
Adults (31 years and Above)
Retinoids
Antibiotics
Salicylic Acid
Benzoyl Peroxide
Others
Low Price Tier
Mid Price Tier
High Price Tier
In-Clinic / In-Office Treatment
At-Home Treatment
Hybrid Treatment Model
Facial Acne Treatment
Body Acne Treatment
Scalp Acne Treatment
Dermatologist & Aesthetician
Pharmacies & drug store
E-Commerce
Others
Dermatology Clinics
Hospitals & Healthcare Facilities
Medical Spas
Cosmetic Surgeons
Pharmacies / Chemists
Teledermatology Services
Other End Users
Bayer AG
Pfizer Inc.
GlaxoSmithKline group of companies
Pfizer Inc
F. Hoffmann-La Roche
Galderma
Vinapharco
BEIERSDORF
Dermafirm
Tu Hao Flagship Store
Bioderma
Bo International Pvt. Ltd.
Glenmark Pharmaceuticals Ltd
Kenvue Inc.
Rixin Cosmetics Co., Ltd.
Report Scope and Segmentation:
|
Parameters |
Details |
|
Market Size in 2026 |
USD 53.61 Million |
|
Revenue Forecast in 2035 |
USD 122.89 Million |
|
Growth Rate |
CAGR of 9.66% from 2026 to 2035 |
|
Analysis Period |
2025–2035 |
|
Base Year Considered |
2025 |
|
Forecast Period |
2026–2035 |
|
Market Size Estimation |
Million (USD) |
|
Growth Factors |
|
|
Companies Profiled |
15 |
|
Market Share |
Available for 10 companies |
|
Customization Scope |
Free customization (equivalent to up to 80 analyst-working hours) after purchase. Addition or alteration to country, regional & segment scope. |
|
Pricing and Purchase Options |
Avail customized purchase options to meet your exact research needs. |
|
Approach |
In-depth primary and secondary research; proprietary databases; rigorous quality control and validation measures. |
|
Analytical Tools |
Porter's Five Forces, SWOT, value chain, and Harvey ball analysis to assess competitive intensity, stakeholder roles, and relative impact of key factors. |